398 results on '"Anderluh, Marko"'
Search Results
2. The overview of development of novel bacterial topoisomerase inhibitors effective against multidrug-resistant bacteria in an academic environment: From early hits to in vivo active antibacterials
3. Amide containing NBTI antibacterials with reduced hERG inhibition, retained antimicrobial activity against gram-positive bacteria and in vivo efficacy
4. Diminishing hERG inhibitory activity of aminopiperidine-naphthyridine linked NBTI antibacterials by structural and physicochemical optimizations
5. Modulating antibody N-glycosylation through feed additives using a multi-tiered approach.
6. Galectin‐8 inhibition and functions in immune response and tumor biology.
7. Galectin-8N-Selective 4‑Halophenylphthalazinone-Galactals Double π‑Stack in a Unique Pocket.
8. Targeting N -Acetylglucosaminidase in Staphylococcus aureus with Iminosugar Inhibitors.
9. Benzimidazole–galactosides bind selectively to the Galectin-8 N-Terminal domain: Structure-based design and optimisation
10. Combining cross-coupling reaction and Knoevenagel condensation in the synthesis of glyco-BODIPY probes for DC-SIGN super-resolution bioimaging
11. Does targeting Arg98 of FimH lead to high affinity antagonists?
12. Discovery of two non-UDP-mimic inhibitors of O-GlcNAc transferase by screening a DNA-encoded library
13. CCK2R antagonists: from SAR to clinical trials
14. Discovery of Two Non-Udp-Mimic Inhibitors of O-Glcnac Transferase by Screening a Dna-Encoded Library
15. The overview of development of novel bacterial topoisomerase inhibitors effective against multidrug-resistant bacteria in an academic environment: from early hits to in vivo active antibacterials
16. Potent DNA gyrase inhibitors bind asymmetrically to their target using symmetrical bifurcated halogen bonds
17. Insight into structural requirements for selective and/or dual CXCR3 and CXCR4 allosteric modulators
18. Exploring Alternative Pathways to Target Bacterial Type II Topoisomerases Using NBTI Antibacterials: Beyond Halogen-Bonding Interactions
19. Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity
20. Linker-switch approach towards new ATP binding site inhibitors of DNA gyrase B
21. Identification of indole scaffold-based dual inhibitors of NOD1 and NOD2
22. Design of OSMI‐4 analogs using scaffold hopping: investigating the importance of the uridine mimic in the binding of OGT inhibitors
23. Design of OSMI-4 Analogs Using Scaffold Hopping: Investigating the Importance of the Uridine Mimic in the Binding of OGT Inhibitors
24. Benzimidazole-galactosides bind selectively to the galectin-8 N-terminal domain
25. Monovalent mannose-based DC-SIGN antagonists: Targeting the hydrophobic groove of the receptor
26. Design, synthesis and evaluation of second generation MurF inhibitors based on a cyanothiophene scaffold
27. The Comparison of Docking Search Algorithms and Scoring Functions
28. The Structural Features of Novel Bacterial Topoisomerase Inhibitors That Define Their Activity on Topoisomerase IV
29. Discovery of a New Drug-like Series of OGT Inhibitors by Virtual Screening
30. Discovery of a New Drug-like Series of OGT Inhibitors by Virtual Screening
31. Synthesis and biological evaluation of piperazine derivatives as novel isoform selective voltage-gated sodium (Nav) 1.3 channel modulators
32. Front Cover: Selective Monovalent Galectin‐8 Ligands Based on 3‐Lactoylgalactoside (ChemMedChem 3/2022)
33. Repurposing of 8‐Hydroxyquinoline‐Based Butyrylcholinesterase and Cathepsin B Ligands as Potent Nonpeptidic Deoxyribonuclease I Inhibitors
34. The Comparison of Docking Search Algorithms and Scoring Functions
35. Design and synthesis of novel 3-triazolyl-1-thiogalactosides as galectin-1, -3 and -8 inhibitors
36. Selective Galectin‐8N Ligands: The Design and Synthesis of Phthalazinone‐d‐Galactals
37. Inhibition of O-GlcNAc Transferase Alters the Differentiation and Maturation Process of Human Monocyte Derived Dendritic Cells
38. Structure-Guided Design of d-Galactal Derivatives with High Affinity and Selectivity for the Galectin-8 N-Terminal Domain
39. 2-Amino-5-alkylidenethiazol-4-ones as promising lipid peroxidation inhibitors
40. Antimicrobial activity and cytotoxicity of some 2-amino-5-alkylidene-thiazol-4-ones
41. Monovalent and bivalent N-fucosyl amides as high affinity ligands for Pseudomonas aeruginosa PA-IIL lectin
42. An assay for functional dendritic cell-specific ICAM-3-grabbing nonintegrin (DC–SIGN) inhibitors of human dendritic cell adhesion
43. 3D QSAR study, synthesis, and in vitro evaluation of (+)-5-FBVM as potential PET radioligand for the vesicular acetylcholine transporter (VAChT)
44. Selective Monovalent Galectin‐8 Ligands Based on 3‐Lactoylgalactoside
45. Structurally Optimized Potent Dual-Targeting NBTI Antibacterials with an Enhanced Bifurcated Halogen-Bonding Propensity
46. Purine adducts as a presumable missing link for aristolochic acid nephropathy‐related cellular energy crisis, potential anti‐fibrotic prevention and treatment
47. Three-component one-pot synthetic route to 2-amino-5-alkylidene-thiazol-4-ones
48. Overview of the Assays to Probe O-Linked β-N-Acetylglucosamine Transferase Binding and Activity
49. A Fine-Tuned Lipophilicity/Hydrophilicity Ratio Governs Antibacterial Potency and Selectivity of Bifurcated Halogen Bond-Forming NBTIs
50. Recent advances on smart glycoconjugate vaccines in infections and cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.